Nephro Care India (NSE:NEPHROCARE) EPS (Basic): ₹0.26 (TTM As of Dec. 2025)


NSE:NEPHROCARE Nephro Care India Ltd NSE:NEPHROCARE
19 GF Score
Price ₹67.35
! 3 Warning Signs
View Full Analysis

What is Nephro Care India EPS (Basic)?

Nephro Care India NSE:NEPHROCARE 19 EPS (Basic) is ₹0.26 as of Dec. 2025. GuruFocus rates NSE:NEPHROCARE with a GF Score™ of 19/100. The stock has 3 warning signs investors should review.

Nephro Care India's basic earnings per share (Basic EPS) for the three months ended in Dec. 2025 was ₹0.26. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was ₹0.26.

Nephro Care India's EPS (Diluted) for the three months ended in Dec. 2025 was ₹0.26. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was ₹0.26.

Nephro Care India's EPS without NRI for the three months ended in Dec. 2025 was ₹0.26. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 0.26.

During the past 12 months, Nephro Care India's average EPS without NRIGrowth Rate was -56.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Nephro Care India's highest 3-Year average EPS without NRI Growth Rate was 264.40% per year. The lowest was 264.40% per year. And the median was 264.40% per year.

Nephro Care India  (NSE:NEPHROCARE) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Nephro Care India EPS (Basic) Related Terms

Nephro Care India EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Nephro Care India's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nephro Care India EPS (Basic) Chart

Nephro Care India Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
EPS (Basic)
0.05 -0.01 1.18 2.68 2.38

Nephro Care India Quarterly Data
Mar21 Mar22 Mar23 Dec23 Mar24 Sep24 Mar25 Sep25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only 0.61 0.00 0.00 0.00 0.26
NSE:NEPHROCARE
19GF Score
Nephro Care India Ltd NSE:NEPHROCARE
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nephro Care India EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Nephro Care India's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(36.389-0)/15.281
=2.38

Nephro Care India's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(4.209-0)/16.188
=0.26

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹0.26 mean?
Nephro Care India (NSE:NEPHROCARE) has a EPS (Basic) of ₹0.26 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Nephro Care India and its competitors.
Is Nephro Care India's EPS (Basic) too high?
Nephro Care India's current EPS (Basic) is ₹0.26. Overall, Nephro Care India has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Nephro Care India's EPS (Basic) compare to HCA and THC?
Nephro Care India's EPS (Basic) of ₹0.26 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Providers & Services company?
A good EPS (Basic) depends on the Healthcare Providers & Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Nephro Care India and its competitors. Nephro Care India's current EPS (Basic) is ₹0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nephro Care India stock overvalued right now?
Nephro Care India (NSE:NEPHROCARE) has a current EPS (Basic) of ₹0.26. The current EPS (Basic) is ₹0.26. Nephro Care India's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Nephro Care India (NSE:NEPHROCARE), the current EPS (Basic) is ₹0.26 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nephro Care India Business Description

Address c/o EFC India - Millenium City IT Park, Tower 2, 12th Floor, DN 62, DN Block, Sector V, Bidhannagar, Kolkata, WB, IND, 700091
Nephro Care India Ltd is a Kolkata-based healthcare provider specializing in comprehensive medical services for renal patients. The company serves as a one-stop treatment center, offering a broad spectrum of clinical and lifestyle solutions, along with specialized treatments for renal insufficiency. Its holistic care framework addresses not only the medical and physiological aspects of treatment but also focuses on lifestyle and spiritual wellness, providing an integrated approach to patient care.
19GF Score

Get the complete analysis for NSE:NEPHROCARE

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹67.35
Price